Boston Scientific's Lotus Retirement Spells Job Loss

Discussion in 'Pharma/Biotech Companies - In the News' started by cafead, Nov 18, 2020 at 11:32 PM.

  1. cafead

    cafead Administrator
    Staff Member

    Joined:
    Nov 21, 2001
    Messages:
    32,990
    Likes Received:
    3
    via Boston Scientific shook up the cardiovascular world this week with its decision to retire its entire Lotus transcatheter aortic valve replacement (TAVR) platform. That decision translates into job loss for 106 Minnesota-based employees, according to reports from Bring Me the News and MassDevice.

    article source